Generic Vytorin introduced by Teva

Generic Vytorin introduced by Teva

JERUSALEM, Israel — Teva Pharmaceutical Industries launched generic Vytorin (ezetimibe and simvastatin) tablets in the United States.

ChemSpider 2D Image | ezetimibe | C24H21F2NO3           ChemSpider 2D Image | (+)-Simvastatin | C25H38O5

                        ezetimibe                                             simvastatin

Ezetimibe and simvastatin tablets are a prescription medicine that contains two cholesterol-lowering medicines, ezetimibe and simvastatin, which are used along with diet to lower the level of “bad” cholesterol (low density lipoprotein cholesterol or LDL); increase the level of “good” cholesterol (high density lipoprotein cholesterol or HDL); and lower the level of fat in blood (triglycerides).

Merck’s Vytorin had annual sales of approximately $678 million in the U.S. according to IMS data as of February 2017.

Source: http://www.drugstorenews.com/

April 27, 2017 / Pharma News